Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Asensus Surgical to Host Investor Day on February 21, 2023 | ||
By: GlobeNewswire - 30 Jan 2023 | Back to overview list |
|
RESEARCH TRIANGLE PARK, N.C., Jan. 30, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced that the Company will host an Investor Day on Tuesday, February 21, 2023 in New York City. 2023 Investor Day Overview Date: Tuesday, February 21, 2023 Time: 11:30 AM EST Location: InterContinental New York Barclay Hotel A live webcast of the conference presentation will be available online on the investor relations page of the Company’s website at https://ir.asensus.com/events-and-presentations. Replays of the webcasts will be archived on the website. About Asensus Surgical, Inc. Asensus Surgical, Inc. is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery by unlocking clinical intelligence for surgeons to enable consistently superior outcomes and a new standard of surgery. This builds upon the foundation of Digital Laparoscopy with the Senhance® Surgical System powered by the Intelligent Surgical Unit™ (ISU™) to increase surgeon control and reduce surgical variability. With the addition of machine vision, augmented intelligence, and deep learning capabilities throughout the surgical experience, we intend to holistically address the current clinical, cognitive and economic shortcomings that drive surgical outcomes and value-based healthcare. Learn more about Performance-Guided Surgery and Digital Laparoscopy with the Senhance Surgical System here: www.senhance.com. Now available for sale in the US, EU, Japan, Russia, and select other countries. For a complete list of indications for use, visit: www.senhance.com/indications. For more information, visit www.asensus.com. Follow Asensus Email Alerts: https://ir.asensus.com/email-alerts LinkedIn: https://www.linkedin.com/company/asensus-surgical-inc Twitter: https://twitter.com/AsensusSurgical YouTube: https://www.youtube.com/c/transenterix Vimeo: https://vimeo.com/asxc TikTok: https://www.tiktok.com/@asensus_surgical INVESTOR CONTACT: MEDIA CONTACT:
|
||
|
||
Copyright 2023 GlobeNewswire | Back to overview list |